No Data
Beyond The Numbers: 8 Analysts Discuss Novo Nordisk Stock
Cantor Fitzgerald Reiterates Overweight on Novo Nordisk, Maintains $160 Price Target
Novo Nordisk Analyst Ratings
Novo Nordisk A/S - Share Repurchase Programme
US drug prices have skyrocketed by 40%! Over 30% of people are 'hopeless sighs' about the high cost of drugs, and Biden is urgently pushing measures to address it.
In the past decade, prescription drug prices in the USA have skyrocketed by nearly 40%, far exceeding inflation rates, resulting in about one-third of Americans being unable to purchase medicine from pharmacies.
Alnylam, Lilly, AstraZeneca Among Best Performing Pharmas, Biotechs in Q2